Changes in Organizational Structure- Biotechnology Company

Changes in Organizational Structure- Biotechnology Company

As a senior healthcare executive in a biotechnology company that is growing into new drug research avenues and experiencing rapid growth, I would suggest a number of organizational structure changes to successfully support the new strategic ambitions. First, I would advise setting up distinct divisions or departments for each new drug development strategy. Creating cross-functional teams with specialists in areas like research, clinical trials, regulatory affairs, and manufacturing unique to each medicine would be necessary to achieve this. To ensure focused attention and effective advancement, each division should have its own dedicated resources and leadership. Subsequently, this will simplify decision-making procedures for each route taken in the development of a drug and promote clear responsibility. Hire our assignment writing services if your assignment is devastating you.

Second, I would suggest creating a central research and development (R&D) department in charge of managing the adaptive research on the first drug and assuring ongoing advancements. This centralized organization can work closely with each drug division and take advantage of synergies across various programs. The R&D unit can assist in accelerating the development of all pharmaceuticals while preserving essential adaptability by pooling its knowledge and resources (Tse & Schweizer, 2023). Finally, I would stress how critical it is for employees to collaborate and communicate well across the company. Regular cross-functional meetings, project updates, and knowledge-sharing sessions can help with this. To ensure the overall success of the business, it is essential to promote a culture of collaboration and communication.

A carefully thought-out change management strategy is necessary to make the transition from the current structure to the new one. To reduce interruption and guarantee a smooth transfer, it is advised to use a staged approach (Kuo et al., 2022). This may entail openly discussing any concerns or opposition with staff members, clearly explaining to them the reasoning behind the structural changes, and giving them the tools they need to transition into new jobs. Additionally, it would be essential to closely monitor the reorganization’s development and make adjustments as needed to optimize the structure and guarantee consistency with the strategic aims.

References

Kuo, Y.-H., Leung, J. M. Y., & Yan, Y. (2022). Public transport for smart cities: Recent innovations and future challenges. European Journal of Operational Research. https://doi.org/10.1016/j.ejor.2022.06.057

Tse, V., & Schweizer, L. (2023). Global or local: The future of biotech. Drug Discovery Today, 28(5), 103528. https://doi.org/10.1016/

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

---

The strategy of a strategic plan can sometimes change or shift directions due to a change in the organization. This is fairly common but the strategy that we use to implement this change can greatly impact the overall outcome of the strategic initiative or entire strategic plan.

Imagine you are a top healthcare executive in a biotechnology firm that has grown rapidly due to the first drug of its kind being approved by the Food and Drug Administration. Based on this approval the organization has now decided that it will proceed down two new drug development paths, while they continue ongoing adaptive research on the first drug. The organization has decided that it seems appropriate to reorganize at this time in order to accommodate the new strategic initiatives. What changes in organizational structure would you recommend at this time and exactly how would you go about moving from the current structure to the new one?